- Home
- SFHG vs NXL Comparison
SFHG vs NXL Comparison
Compare SFHG & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- NXL
- Stock Information
- Founded
- SFHG 1993
- NXL 2010
- Country
- SFHG Hong Kong
- NXL United States
- Employees
- SFHG N/A
- NXL N/A
- Industry
- SFHG Publishing
- NXL Medical Specialities
- Sector
- SFHG Consumer Discretionary
- NXL Health Care
- Exchange
- SFHG Nasdaq
- NXL Nasdaq
- Market Cap
- SFHG 14.9M
- NXL 17.8M
- IPO Year
- SFHG 2024
- NXL 2022
- Fundamental
- Price
- SFHG N/A
- NXL $1.86
- Analyst Decision
- SFHG
- NXL Strong Buy
- Analyst Count
- SFHG 0
- NXL 1
- Target Price
- SFHG N/A
- NXL $5.00
- AVG Volume (30 Days)
- SFHG 62.3K
- NXL 9.7M
- Earning Date
- SFHG 04-16-2025
- NXL 11-07-2025
- Dividend Yield
- SFHG N/A
- NXL N/A
- EPS Growth
- SFHG N/A
- NXL N/A
- EPS
- SFHG N/A
- NXL N/A
- Revenue
- SFHG $19,760,935.00
- NXL $174,813.00
- Revenue This Year
- SFHG N/A
- NXL $38.28
- Revenue Next Year
- SFHG N/A
- NXL $185.71
- P/E Ratio
- SFHG N/A
- NXL N/A
- Revenue Growth
- SFHG 30.89
- NXL 16.42
- 52 Week Low
- SFHG $0.55
- NXL $0.59
- 52 Week High
- SFHG $24.00
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- SFHG 35.03
- NXL 80.20
- Support Level
- SFHG $0.64
- NXL $0.86
- Resistance Level
- SFHG $0.71
- NXL $0.97
- Average True Range (ATR)
- SFHG 0.04
- NXL 0.10
- MACD
- SFHG -0.01
- NXL 0.05
- Stochastic Oscillator
- SFHG 8.87
- NXL 69.87
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.